Patents by Inventor Hiroichi Ozaki

Hiroichi Ozaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8072008
    Abstract: A high-sensitivity field effect transistor using as a channel ultrafine fiber elements such as carbon nanotube, and a biosensor using it. The field effect transistor comprises a substrate, a source electrode and a drain electrode arranged on the substrate, a channel for electrically connecting the source electrode with the drain electrode, and a gate electrode causing polarization due to the movement of free electrons in the substrate. For example, the substrate has a support substrate consisting of semiconductor or metal, a first insulating film formed on a first surface of the support substrate, and a second insulating film formed on a second surface of the support substrate, the source electrode, the drain electrode, and the channel arranged on the first insulating film, the gate electrode disposed on the second insulating film.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: December 6, 2011
    Assignees: Mitsumi Electric Co., Ltd., Semicon Craft Technologies
    Inventors: Koichi Mukasa, Kazuhisa Sueoka, Seiji Takeda, Satoshi Hattori, Yoshiki Yamada, Makoto Sawamura, Hiroichi Ozaki, Atsushi Ishii, Motonori Nakamura, Hirotaka Hosoi
  • Publication number: 20100032653
    Abstract: This invention provides a process for producing a carbon nanotube electric field effect transistor that can improve yield in channel preparation. Carbon nanotubes dispersed in a mixed acid composed of sulfuric acid and nitric acid are subjected to radical treatment with aqueous hydrogen peroxide to cut the carbon nanotubes and thus to provide carboxyl-introduced carbon nanotube fragments. The carbon nanotube fragments are attached, through a covalent bond and/or an electrostatic bond, to a site, where a source electrode is to be formed, and a site where a drain electrode is to be formed, in a substrate with a functional group, to be attached to a carboxyl group, introduced thereinto. The carbon nanotube fragments attached to the substrate are attached to carbon nanotubes as channels through n-n interaction to fix the carbon nanotubes as channels to the substrate.
    Type: Application
    Filed: March 28, 2007
    Publication date: February 11, 2010
    Applicant: National University Corpration Hokkaido University
    Inventors: Seiji Takeda, Koichi Mukasa, Atsushi Ishii, Hiroichi Ozaki, Makoto Sawamura, Hirotaka Hosoi, Satoshi Hattori, Yoshiki Yamada, Kazuhisa Sueoka
  • Publication number: 20080283875
    Abstract: A high-sensitivity field effect transistor using as a channel ultrafine fiber elements such as carbon nanotube, and a biosensor using it. The field effect transistor comprises a substrate, a source electrode and a drain electrode arranged on the substrate, a channel for electrically connecting the source electrode with the drain electrode, and a gate electrode causing polarization due to the movement of free electrons in the substrate. For example, the substrate has a support substrate consisting of semiconductor or metal, a first insulating film formed on a first surface of the support substrate, and a second insulating film formed on a second surface of the support substrate, the source electrode, the drain electrode, and the channel arranged on the first insulating film, the gate electrode disposed on the second insulating film.
    Type: Application
    Filed: December 13, 2007
    Publication date: November 20, 2008
    Applicants: MITSUMI ELECTRIC CO., LTD., Semicon Craft Technologies
    Inventors: Koichi MUKASA, Kazuhisa SUEOKA, Seiji TAKEDA, Satoshi HATTORI, Yoshiki YAMADA, Makoto SAWAMURA, Hiroichi OZAKI, Atsushi ISHII, Motonori NAKAMURA, Hirotaka HOSOI
  • Patent number: 7037707
    Abstract: The present invention is based on the discovery that a high titer reassortant influenza virus is produced in mammalian cell culture by replacing the NS gene of the A/PuertoRico/3/24 master strain with the NS gene of the A/England/1/53 strain. The invention provides influenza viruses and vaccines generated in mammalian cells as well as methods for producing such. The invention further provides an influenza virus master strain and kits for generating reassortant influenza viruses in mammalian cell culture and methods of making and using the master strain.
    Type: Grant
    Filed: September 4, 2003
    Date of Patent: May 2, 2006
    Assignee: St. Jude Children's Research Hospital
    Inventors: Robert Gordon Webster, Richard John Webby, Hiroichi Ozaki
  • Publication number: 20050054846
    Abstract: The present invention is based on the discovery that a high titer reassortant influenza virus is produced in mammalian cell culture by replacing the NS gene of the A/PuertoRico/3/24 master strain with the NS gene of the A/England/1/53 strain. The invention provides influenza viruses and vaccines generated in mammalian cells as well as methods for producing such. The invention further provides an influenza virus master strain and kits for generating reassortant influenza viruses in mammalian cell culture and methods of making and using the master strain.
    Type: Application
    Filed: September 4, 2003
    Publication date: March 10, 2005
    Inventors: Robert Webster, Richard Webby, Hiroichi Ozaki